Clinical role of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasia.

BACKGROUND The clinical role of atrial fibrillation/atrial flutter (AF-AFl) and variables predicting these arrhythmias are not well defined in patients with arrhythmogenic right ventricular dysplasia (ARVD). We hypothesized that transthoracic echocardiography (TTE) and 12-lead electrocardiography (ECG) would be helpful in predicting AF-AFl in these patients. METHODS AND RESULTS: ECGs and TTEs of 90 patients diagnosed with definite or borderline ARVD (2010 Task Force Criteria) were analyzed. Data were compared in (1) patients with AF-AFl and (2) all other patients. A total of 18 (20%) patients experienced AF-AFl during a median follow-up of 5.8 years (interquartile range 2.0-10.4). Kaplan-Meier analysis revealed reduced times to AF-AFl among patients with echocardiographic RV fractional area change <27% (P<0.001), left atrial diameter ≥24.4 mm/m(2)(parasternal long-axis, P=0.001), and right atrial short-axis diameter ≥22.1 mm/m(2)(apical 4-chamber view, P=0.05). From all ECG variables, P mitrale conferred the highest hazard ratio (3.37, 95% confidence interval 0.92-12.36, P=0.067). Five patients with AF-AFl experienced inappropriate implantable cardioverter-defibrillator (ICD) shocks compared with 4 without AF-AFl (36% vs. 9%, P=0.03). AF-AFl was more prevalent in heart-transplant patients and those who died of cardiac causes (56% vs. 16%, P=0.014). CONCLUSIONS AF-AFl is associated with inappropriate ICD shocks, heart transplantation, and cardiac death in patients with ARVD. Evidence of reduced RV function and atrial dilation helps to identify the ARVD patients at increased risk for AF-AFl.

[1]  L. Held,et al.  Different Prognostic Value of Functional Right Ventricular Parameters in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2014, Circulation. Cardiovascular imaging.

[2]  H. Calkins,et al.  Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2013, Heart rhythm.

[3]  Sanjay Rajagopalan,et al.  Beyond Medications and Diet: Alternative Approaches to Lowering Blood Pressure A Scientific Statement From the American Heart Association , 2013, Hypertension.

[4]  M. Horie,et al.  Age-dependent clinical and genetic characteristics in Japanese patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[5]  L. Held,et al.  Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy. , 2013, The American journal of cardiology.

[6]  O. Senn,et al.  Right heart assessment by echocardiography: gender and body size matters. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  Ashok J. Shah,et al.  Heterogeneous response of J-wave syndromes to beta-adrenergic stimulation. , 2012, Heart rhythm.

[8]  H. Calkins,et al.  Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs , 2012, Nature.

[9]  M. Kurabayashi,et al.  Compound and digenic heterozygosity in desmosome genes as a cause of arrhythmogenic right ventricular cardiomyopathy in Japanese patients. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[10]  A. Aribas,et al.  P-wave Dispersion for Predicting Paroxysmal Atrial Fibrillation in Acute Ischemic Stroke , 2011, International journal of medical sciences.

[11]  T. Lüscher,et al.  Electrocardiographic changes in early recognition of Fabry disease , 2011, Heart.

[12]  F. Marchlinski,et al.  Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and ventricular tachycardia. , 2010, The American journal of cardiology.

[13]  J. Deharo,et al.  Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[15]  E. W. Hancock,et al.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American , 2009, Journal of the American College of Cardiology.

[16]  E. W. Hancock,et al.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the , 2009, Journal of the American College of Cardiology.

[17]  M. Josephson,et al.  Accuracy of electrocardiographic criteria for atrial enlargement: validation with cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[18]  Dirk De Bacquer,et al.  Long-term prognostic value of p-wave characteristics for the development of atrial fibrillation in subjects aged 55 to 74 years at baseline. , 2007, The American journal of cardiology.

[19]  K. Aytemir,et al.  P Wave Dispersion Predicts Recurrence of Paroxysmal Atrial Fibrillation in Patients with Atrioventricular Nodal Reentrant Tachycardia Treated with Radiofrequency Catheter Ablation , 2006, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[20]  A. Hofman,et al.  Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.

[21]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[22]  A. Grande,et al.  Heterotopic heart transplantation: three dimensional image , 2005, Heart.

[23]  M. Wijffels.  The Natural History of Atrial Fibrillation: , 1999, Journal of cardiovascular electrophysiology.

[24]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[25]  S. Sideris,et al.  Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. , 1998, American heart journal.

[26]  B. Brembilla-Perrot,et al.  Increased atrial vulnerability in arrhythmogenic right ventricular disease. , 1998, American heart journal.

[27]  P. Coumel,et al.  Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease. , 1996, European heart journal.

[28]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[29]  S. Vaziri,et al.  Echocardiographic Predictors of Nonrheumatic Atrial Fibrillation: The Framingham Heart Study , 1994, Circulation.

[30]  F. Marchlinski,et al.  Electrocardiographically Documented Unnecessary, Spontaneous Shocks in 241 Patients With Implantable Cardioverter Defibrillators , 1992, Pacing and clinical electrophysiology : PACE.

[31]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[32]  R. Frank,et al.  Frequency of supraventricular tachyarrhythmias in arrhythmogenic right ventricular dysplasia. , 1991, The American journal of cardiology.

[33]  G. Thiene,et al.  Familial occurrence of right ventricular dysplasia: a study involving nine families. , 1988, Journal of the American College of Cardiology.

[34]  F. Morady,et al.  Unusual features of arrhythmogenic right ventricular dysplasia. , 1984, The American journal of cardiology.

[35]  Hao Wang,et al.  Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. , 2015, Chest.

[36]  J. B. Oliveira,et al.  PKP2 mutations in sudden death from arrhythmogenic right ventricular cardiomyopathy (ARVC) and sudden unexpected death with negative autopsy (SUDNA). , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[37]  C. Appleton,et al.  Relation of electrocardiographic criteria for left atrial enlargement to two-dimensional echocardiographic left atrial volume measurements. , 2007, The American journal of cardiology.